Texas Yale Capital Corp’s Vicarious Surgical Inc Warrants RBOT.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-282,830
Closed -$5.66K 504
2025
Q3
$5.66K Hold
282,830
﹤0.01% 482
2025
Q2
$8.23K Hold
282,830
﹤0.01% 465
2025
Q1
$10.2K Hold
282,830
﹤0.01% 450
2024
Q4
$6.94K Hold
282,830
﹤0.01% 461
2024
Q3
$12.7K Hold
282,830
﹤0.01% 455
2024
Q2
$11.3K Hold
282,830
﹤0.01% 439
2024
Q1
$24.7K Hold
282,830
﹤0.01% 439
2023
Q4
$8.48K Hold
282,830
﹤0.01% 435
2023
Q3
$21.7K Sell
282,830
-50,000
-15% -$8.14K ﹤0.01% 416
2023
Q2
$73.2K Buy
332,830
+121,630
+58% +$29.2K ﹤0.01% 428
2023
Q1
$83.9K Buy
211,200
+98,500
+87% +$28.9K ﹤0.01% 437
2022
Q4
$16.9K Hold
112,700
﹤0.01% 450
2022
Q3
$50K Buy
112,700
+1,500
+1% +$758 ﹤0.01% 442
2022
Q2
$34K Buy
111,200
+47,230
+74% +$26.5K ﹤0.01% 442
2022
Q1
$53K Buy
63,970
+37,770
+144% +$37.9K ﹤0.01% 461
2021
Q4
$56K Hold
26,200
﹤0.01% 465
2021
Q3
$58K Buy
+26,200
New +$52.9K ﹤0.01% 458

Texas Yale Capital Corp's RBOT.WS Position: Q4 2025 in Review

Texas Yale Capital Corp sold out of Vicarious Surgical Inc Warrants (RBOT.WS) in Q4 2025, closing a stake of 282,830 shares — an estimated $5.66K sold.

Texas Yale Capital Corp first reported a position in RBOT.WS in Q3 2021 and held it in 17 quarters. The position peaked at $83.9K in Q1 2023. 0 funds tracked by Wall St. Rank hold RBOT.WS as of Q4 2025.

  • Texas Yale Capital Corp reported no remaining Vicarious Surgical Inc Warrants position as of Q4 2025 after selling out during the quarter.
  • Texas Yale Capital Corp sold 282,830 Vicarious Surgical Inc Warrants shares in Q4 2025, an estimated $5.66K.
  • Texas Yale Capital Corp first reported a position in Vicarious Surgical Inc Warrants in Q3 2021 and held it in 17 quarters.
  • Texas Yale Capital Corp's Vicarious Surgical Inc Warrants position peaked at $83.9K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Vicarious Surgical Inc Warrants as of Q4 2025.

Based on Texas Yale Capital Corp's 13F filing for Q4 2025, filed 10 Feb 2026.